---
title: "RASi ACEI ARB"
date: "2023-07-29"
enableToc: false
tags:
  - building
alias:
  - ARB
  - ACEI
  - RASi
---

> [!info]
>
> 🌱 來自：[[Treatment of Chronic HF with Reduced EF]]

# RASi ACEI ARB

> Choose one of ARNI (ARB + neprilysin inhib),
> ACEI or ARB

36-hr washout when transitioning ACEI to ARNI

- ARNI preferred RASi in NYHA II-IV.
  - Neutral endopeptidase (NEP, aka neprilysin) degrades natriuretic peptides,
    - bradykinin & angiotensins.
  - Valsartan + sacubitril (NEPi) ↓ CV mort & HF hosp c/w ACEi;
    - ↑ HoTN, AKI (NEJM 2014;371:993 & 2019;380:539).
  - Contraindicated if h/o angioedema.
  - BNP 應該會上升 ↑ ，因 為: ARNI 含有 neprilysin inhibitor，
    - 會減少 BNP 的 → 降解，
    - 使用 ARNI 的 → 期間，可以 ✔ 用 NT pro-BNP 來監測 HF
- ACEI: if unable to tolerate or afford ARNI. ↓ mortality vs. placebo.
  - High-dose more effic. than low.
- Watch for
  - ↑ Cr,
  - ↑ K (ameliorate by low-K diet, diuretics, K binders),
  - cough,
  - angioedema.
- ARB:
  - consider if cannot tolerate
  - ACEI (eg, b/c cough) as noninferior
  -
